Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Platelet glycoprotein Ilb/IIIa receptor antagonists

Atwater BD, Roe MT, Mahaffey KW. Platelet glycoprotein Ilb/IIIa receptor antagonists in non-ST segment elevation acute coronary syndromes a review and guide to patient selection. Drugs. 2005 65 313-324. [Pg.317]

Ferguson JJ, Zaqqa M. Platelet glycoprotein Ilb/IIIa receptor antagonists. Drugs 1999 S8 965-82. [Pg.95]

Hetero Diels-Alder-Biocatalysis approach for the synthesis of (S)-3- 2-[(methyl-sulfonyl) oxy]ethoxy -4-(triphenylmeth-oxy)-l-butanol methanesulfo-nate successful application of an enzyme resolution process Multi-kilo resolution of XU305, a key intermediate to the platelet glycoprotein Ilb/IIIa receptor antagonist roxifiban via kinetic and dynamic enzymatic resolution... [Pg.10]

Rare cases of acute profound thrombocytopenia (i.e., platelet count <20,000/mm ) have been reported with the glycoprotein Ilb/IIIa receptor antagonist abciximab. ° Although the mechanism is unknown, it is thought that abciximab binding to the glyco-... [Pg.1884]

Eptifibatide is a reversible inhibitor of the glycoprotein Ilh/nia receptor, an integrin on the surface of platelets that serves as a key regulator of platelet aggregation. Glycoprotein Ilb/IIIa receptor antagonists help to prevent platelet-induced occlusion of coronary stents. The answer is (E). [Pg.313]

In addition, Asano et al. have reported that DKR of amino acid amides, such as alanine amide, could be performed by using a combination of two enzymes, o-aminopeptidase and a-amino-s-caprolactam racemase, yielding the corresponding o-amino acids. A lipase-catalysed hydrolysis has constituted the key step of a total synthesis of roxifiban, a potent antagonist of the platelet glycoprotein Ilb/IIIa receptor. The DKR of an isobutyl ester to form the corresponding acid in both high yield and enantioselectivity is depicted in Scheme 3.46. [Pg.169]

PTCA, unstable angina, non-Qwave MI Glycoprotein Ilb/IIIa platelet receptor antagonists Abciximab Eptifibatide Tirofiban Reduce infarction, revascularization, death (composite) EPIC EPILOG PRISM PRISM-PLUS PURSUIT RESTORE >33,000 12... [Pg.4]

Cook NS, Zerwes H-G, Tapparelli C et al. (1993) Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood activation by ADP and thrombin receptor peptide and inhibition by glycoprotein Ilb/IIIa antagonists. Thromb Haemostasis 70 531-539... [Pg.314]


See other pages where Platelet glycoprotein Ilb/IIIa receptor antagonists is mentioned: [Pg.264]    [Pg.2810]    [Pg.264]    [Pg.2810]    [Pg.261]    [Pg.320]    [Pg.412]    [Pg.465]    [Pg.548]    [Pg.1703]    [Pg.600]    [Pg.485]    [Pg.2849]    [Pg.176]    [Pg.145]    [Pg.155]    [Pg.738]    [Pg.534]    [Pg.2]    [Pg.276]   
See also in sourсe #XX -- [ Pg.3 , Pg.3 , Pg.29 , Pg.318 , Pg.319 ]




SEARCH



Glycoprotein Ilb/IIIa

Glycoprotein Ilb/IIIa receptor

Glycoprotein platelet receptor antagonists

Glycoprotein- -receptors

Platelet glycoprotein

Platelets receptors

© 2024 chempedia.info